210 related articles for article (PubMed ID: 35235467)
21. Mutation analysis and molecular genetics of epidermolysis bullosa.
Pulkkinen L; Uitto J
Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
[TBL] [Abstract][Full Text] [Related]
22. The long and winding road that leads to a cure for epidermolysis bullosa.
Carulli S; Contin R; De Rosa L; Pellegrini G; De Luca M
Regen Med; 2013 Jul; 8(4):467-81. PubMed ID: 23826700
[TBL] [Abstract][Full Text] [Related]
23. Inherited epidermolysis bullosa: update on the clinical and genetic aspects.
Mariath LM; Santin JT; Schuler-Faccini L; Kiszewski AE
An Bras Dermatol; 2020; 95(5):551-569. PubMed ID: 32732072
[TBL] [Abstract][Full Text] [Related]
24. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.
Natsuga K; Shinkuma S; Hsu CK; Fujita Y; Ishiko A; Tamai K; McGrath JA
J Dermatol Sci; 2021 Dec; 104(3):164-176. PubMed ID: 34916041
[TBL] [Abstract][Full Text] [Related]
25. Multidisciplinary care for patients with epidermolysis bullosa from birth to adolescence: experience of one Italian reference center.
Retrosi C; Diociaiuti A; De Ranieri C; Corbeddu M; Carnevale C; Giancristoforo S; Marchili MR; Salvatori G; Atti MLCD; El Hachem M; Raponi M
Ital J Pediatr; 2022 Apr; 48(1):58. PubMed ID: 35414096
[TBL] [Abstract][Full Text] [Related]
26. The design and optimization of RNA trans-splicing molecules for skin cancer therapy.
Gruber C; Koller U; Murauer EM; Hainzl S; Hüttner C; Kocher T; South AP; Hintner H; Bauer JW
Mol Oncol; 2013 Dec; 7(6):1056-68. PubMed ID: 23998959
[TBL] [Abstract][Full Text] [Related]
27. Molecular therapies for epidermolysis bullosa.
Has C; Kiritsi D
G Ital Dermatol Venereol; 2013 Feb; 148(1):65-72. PubMed ID: 23407078
[TBL] [Abstract][Full Text] [Related]
28. 5'RNA
Mayr E; Ablinger M; Lettner T; Murauer EM; Guttmann-Gruber C; Piñón Hofbauer J; Hainzl S; Kaiser M; Klausegger A; Bauer JW; Koller U; Wally V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163654
[TBL] [Abstract][Full Text] [Related]
29. Translational perspectives to treat Epidermolysis bullosa-Where do we stand?
Prodinger C; Bauer JW; Laimer M
Exp Dermatol; 2020 Nov; 29(11):1112-1122. PubMed ID: 33043517
[TBL] [Abstract][Full Text] [Related]
30. Oral Alterations in Heritable Epidermolysis Bullosa: A Clinical Study and Literature Review.
Polizzi A; Santonocito S; Patini R; Quinzi V; Mummolo S; Leonardi R; Bianchi A; Isola G
Biomed Res Int; 2022; 2022():6493156. PubMed ID: 35686231
[TBL] [Abstract][Full Text] [Related]
31. CRISPR/Cas9 gene editing for genodermatoses: progress and perspectives.
Naso G; Petrova A
Emerg Top Life Sci; 2019 May; 3(3):313-326. PubMed ID: 33523138
[TBL] [Abstract][Full Text] [Related]
32. Stop codon readthrough as a treatment option for epidermolysis bullosa-Where we are and where we are going.
Zandanell J; Wießner M; Bauer JW; Wagner RN
Exp Dermatol; 2024 Mar; 33(3):e15042. PubMed ID: 38459626
[TBL] [Abstract][Full Text] [Related]
33. [Hereditary blistering diseases. Symptoms, diagnosis and treatment of epidermolysis bullosa].
Laimer M; Lanschützer CM; Nischler E; Klausegger A; Diem A; Pohla-Gubo G; Bauer JW; Hintner H
Hautarzt; 2009 May; 60(5):378-88. PubMed ID: 19430749
[TBL] [Abstract][Full Text] [Related]
34. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
Intong LR; Murrell DF
Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
[TBL] [Abstract][Full Text] [Related]
35. [Syndromes 13. Epidermolysis bullosa].
Meijndert L; Jonkman MF
Ned Tijdschr Tandheelkd; 1999 Aug; 106(8):302-5. PubMed ID: 11930425
[TBL] [Abstract][Full Text] [Related]
36. Access to wound dressings for patients living with epidermolysis bullosa - an Australian perspective.
Stevens LJ
Int Wound J; 2014 Oct; 11(5):505-8. PubMed ID: 23174001
[TBL] [Abstract][Full Text] [Related]
37. Epidermolysis bullosa: Advances in research and treatment.
Prodinger C; Reichelt J; Bauer JW; Laimer M
Exp Dermatol; 2019 Oct; 28(10):1176-1189. PubMed ID: 31140655
[TBL] [Abstract][Full Text] [Related]
38. Gene therapy in combination with tissue engineering to treat epidermolysis bullosa.
Ferrari S; Pellegrini G; Matsui T; Mavilio F; De Luca M
Expert Opin Biol Ther; 2006 Apr; 6(4):367-78. PubMed ID: 16548763
[TBL] [Abstract][Full Text] [Related]
39. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
March OP; Reichelt J; Koller U
Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
[TBL] [Abstract][Full Text] [Related]
40. Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa.
El Hachem M; Zambruno G; Bourdon-Lanoy E; Ciasulli A; Buisson C; Hadj-Rabia S; Diociaiuti A; Gouveia CF; Hernández-Martín A; de Lucas Laguna R; Dolenc-Voljč M; Tadini G; Salvatori G; De Ranieri C; Leclerc-Mercier S; Bodemer C
Orphanet J Rare Dis; 2014 May; 9():76. PubMed ID: 24884811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
